Feeds:
Posts
Comments

Posts Tagged ‘Johnson & Johnson’

JULY 12: ASSOCIATED PRESS: Johnson & Johnson says it has completed its $US893.7 million acquisition of Cougar Biotechnology Inc, a development stage company that is testing a potential vaccine for prostate cancer. Los Angeles-based Cougar is conducting two late stage clinical trials of abiraterone acetate as a treatment for prostate cancer. READ MORE>

Read Full Post »

JUNE 6: BUSINESSWEEK:  A top Johnson & Johnson researcher says the company will cure, prevent or stifle cancer by producing better-targeted drugs, paired with improved diagnostic tests. J&J has two compounds in late-stage testing for prostate cancer. READ MORE>

Read Full Post »

MAY 28: NEW JERSEY BUSINESS NEWS: Cougar Biotechnology, the developer of cancer medicines that Johnson & Johnson agreed to buy last week, said its lead experimental drug worked against prostate tumours in a company-sponsored study. READ MORE>

Read Full Post »